PeopleBio, Inc. Logo

PeopleBio, Inc.

Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.

304840 | KO

Overview

Corporate Details

ISIN(s):
KR7304840002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 242, C동 6층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases, particularly neurodegenerative conditions. The company's core innovation is its proprietary Multimer Detection System (MDS) technology, an immunoassay platform used to create simple and reliable blood tests. Its flagship product, the OAβ Test, is a blood-based diagnostic tool for the early detection of Alzheimer's disease. The test functions by measuring the oligomerization levels of beta-amyloid, a key biomarker of the disease, aiming to enable earlier diagnosis and intervention.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 13.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.0 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.9 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.1 MB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 1.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.1 KB
2025-02-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 13.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-22 00:00
Related Party Transaction
[기재정정]금전대여결정
Korean 21.1 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all PeopleBio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PeopleBio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PeopleBio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.